Aun Raza
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 7
- Drug Solubulity and Delivery Systems 4
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 9
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 5
- Molecular Medicine top 5%
- Food Science top 5%
-
- RNA Interference and Gene Delivery 5
-
- Nanoplatforms for cancer theranostics 5
-
- Surfactants and Colloidal Systems 3
-
- Dendrimers and Hyperbranched Polymers 3
Aun Raza
47 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 122
- Pharmaceutical Science 197
- Biomaterials 356
- Biochemistry 105
- Molecular Medicine 75
- Food Science 152
Countries citing papers authored by Aun Raza
This map shows the geographic impact of Aun Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aun Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aun Raza more than expected).
Fields of papers citing papers by Aun Raza
This network shows the impact of papers produced by Aun Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aun Raza. The network helps show where Aun Raza may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aun Raza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 13 | |
| 5 | 2024 | 41 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 85 | |
| 9 | 2022 | 19 | |
| 10 | 2022 | 37 | |
| 11 | 2021 | 31 | |
| 12 | 2021 | 3 | |
| 13 | 2020 | 91 | |
| 14 | 2020 | 56 | |
| 15 | 2019 | 102 | |
| 16 | Clinical features and outcomes of Candidaemia in cancer patients: Results from Pakistan. | 2016 | 9 |
| 17 | Shigella infections: A two year experience in cancer patients. | 2016 | 2 |
| 18 | 2016 | 87 | |
| 19 | 2016 | 20 | |
| 20 | Prevalence and chemotherapy of ascariasis in buffaloes under farm conditions | 1998 | 1 |
About Aun Raza
Aun Raza is a scholar working on Pharmaceutical Science, Biomaterials and Biochemistry, having authored 50 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (7 papers), RNA Interference and Gene Delivery (5 papers), Phytochemicals and Antioxidant Activities (5 papers), Nanoplatforms for cancer theranostics (5 papers), Drug Solubulity and Delivery Systems (4 papers), Surfactants and Colloidal Systems (3 papers) and Dendrimers and Hyperbranched Polymers (3 papers). The work is most often cited by research in Pharmaceutical Science (197 citations), Biomaterials (356 citations) and Biochemistry (105 citations). Aun Raza has collaborated with scholars based in China, Australia and Pakistan. Frequent co-authors include Seyed Ebrahim Alavi, Hasan Ebrahimi Shahmabadi, Xiuquan Xu, Jian Tang, Amirali Popat, Li Feng, Peter J. Cabot, Maedeh Koohi Moftakhari Esfahani, Fekade B. Sime and James R. Falconer. Their work appears in journals such as Drug Discovery Today, Pharmaceutics, Journal of Drug Delivery Science and Technology, Journal of Pharmaceutical Sciences and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.